Inforlife patents expiration
1. Midazolam In 0.9% Sodium Chloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10966990 | INFORLIFE | Midazolam in flexible bags |
Jun, 2038
(14 years from now) | |
Drugs and Companies using MIDAZOLAM ingredient
Market Authorisation Date: 22 March, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of MIDAZOLAM IN 0.9% SODIUM CHLORIDE before it's drug patent expiration?
More Information on Dosage
MIDAZOLAM IN 0.9% SODIUM CHLORIDE family patents
2. Norepinephrine Bitartrate In 0.9% Sodium Chloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10888534 | INFORLIFE | Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags |
Apr, 2039
(15 years from now) | |
Drugs and Companies using NOREPINEPHRINE BITARTRATE ingredient
Market Authorisation Date: 15 September, 2022
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE family patents